Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Professor Dr. Sven Francque

Professor Dr. Sven Francque

individual
Ecosystem influencer

About

Professor Dr. Sven Francque is a physician-scientist and academic expert in nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatohepatitis (MASH). Public company disclosures from Genflow Biosciences describe him as having long-standing expertise in fatty liver disease, vascular changes in steatosis, and clinical trial design. He appears to operate primarily as a scientific and clinical expert rather than as an investor or fund manager.

Areas of interest

hepatologygastroenterologyNAFLDMASHfatty liver diseaseclinical researchclinical trial designlongevity biotech